Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Chewable & Orodispersible Aids
Direct Compression
Taste Masking
Disintegrants & Superdisintegrants
Parenteral
Co-Processed Excipients
Granulation
API Stability Enhancers
Thickeners and Stabilizers
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Fludarabine Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Fludarabine Phosphate manufacturer or Fludarabine Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fludarabine Phosphate manufacturer or Fludarabine Phosphate supplier.
A BCP0726000268 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BCP0726000268, including repackagers and relabelers. The FDA regulates BCP0726000268 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BCP0726000268 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BCP0726000268 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A BCP0726000268 supplier is an individual or a company that provides BCP0726000268 active pharmaceutical ingredient (API) or BCP0726000268 finished formulations upon request. The BCP0726000268 suppliers may include BCP0726000268 API manufacturers, exporters, distributors and traders.
click here to find a list of BCP0726000268 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A BCP0726000268 DMF (Drug Master File) is a document detailing the whole manufacturing process of BCP0726000268 active pharmaceutical ingredient (API) in detail. Different forms of BCP0726000268 DMFs exist exist since differing nations have different regulations, such as BCP0726000268 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A BCP0726000268 DMF submitted to regulatory agencies in the US is known as a USDMF. BCP0726000268 USDMF includes data on BCP0726000268's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The BCP0726000268 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of BCP0726000268 suppliers with USDMF on PharmaCompass.
A BCP0726000268 CEP of the European Pharmacopoeia monograph is often referred to as a BCP0726000268 Certificate of Suitability (COS). The purpose of a BCP0726000268 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of BCP0726000268 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of BCP0726000268 to their clients by showing that a BCP0726000268 CEP has been issued for it. The manufacturer submits a BCP0726000268 CEP (COS) as part of the market authorization procedure, and it takes on the role of a BCP0726000268 CEP holder for the record. Additionally, the data presented in the BCP0726000268 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the BCP0726000268 DMF.
A BCP0726000268 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. BCP0726000268 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of BCP0726000268 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing BCP0726000268 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for BCP0726000268 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture BCP0726000268 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain BCP0726000268 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a BCP0726000268 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of BCP0726000268 suppliers with NDC on PharmaCompass.
BCP0726000268 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BCP0726000268 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right BCP0726000268 GMP manufacturer or BCP0726000268 GMP API supplier for your needs.
A BCP0726000268 CoA (Certificate of Analysis) is a formal document that attests to BCP0726000268's compliance with BCP0726000268 specifications and serves as a tool for batch-level quality control.
BCP0726000268 CoA mostly includes findings from lab analyses of a specific batch. For each BCP0726000268 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BCP0726000268 may be tested according to a variety of international standards, such as European Pharmacopoeia (BCP0726000268 EP), BCP0726000268 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BCP0726000268 USP).
